News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Pharmaceuticals Canada Inc. (NVS) Pulls Prexige From Canada on Safety Issues



10/4/2007 10:04:38 AM

Novartis Pharmaceuticals Canada Inc. has complied with a request from Health Canada to cease the sales and marketing in Canada of Prexige, a COX-2 selective inhibitor for the treatment of osteoarthritis, effective immediately.

Read at Bloomberg
Read at press release
Read at Hemscott
Read at Reuters
Read at MorningStar.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES